摘要:
The invention provides well defined N,N-dialkylalkenyl ester compounds for treating glaucoma or ocular hypertension. The esters of the invention are particularly advantageous due to their stability in aqueous solutions.
摘要:
Compounds comprising (I) or a pharmaceutically acceptable salt or a prodrug thereof, are disclosed, wherein J1, U1, U2, B, Y, and A are as described. Methods, compositions, and medicaments related thereto are also disclosed.
摘要:
Compounds comprising formula (I) or a pharmaceutically acceptable salt thereof, are disclosed, wherein G, B, Y, and A are as described, in claims 1-13 Methods, compositions, and medicaments related thereto are also disclosed, for treating glaucoma, inflamatory bowel disease and baldness.
摘要:
Therapeutic compounds, methods, and compositions are disclosed herein for treating glaucoma and baldness in mammals. The specific compounds are described herein and are modified prostaglandin derivates.
摘要:
Compounds comprising (I) or a pharmaceutically acceptable salt or a prodrug thereof, are disclosed, wherein J 1 , U 1 , U 2 , B, Y, and A are as described. Methods, compositions, and medicaments related thereto are also disclosed.
摘要:
A compound comprising or a pharmaceutically acceptable salt thereof, or a prodrug thereof is disclosed herein. Y, A, and B are as described herein. Methods, compositions, and medicaments related to these compounds are also disclosed.
摘要:
Disclosed herein is a compound comprising a formula (F) or a pharmaceutically acceptable salt or a prodrug or a metabolite thereof; Y is (F) or (F) A is -(CHz)6-. cis -CH2CH=CH-(CH2)3-, or -CH2C≡C-(CH2)3-. wherein 1 or 2 carbon atoms may be substituted with S or O; or A is -(CH2)m-Ar-(CH2)o- wherein Ar is interarylene or heterointerarylene, the sum of m and o is from 1 to 4, and wherein one CH2 may be substituted with S or O; and D is aryl or heteroaryl. Used to treat glaucoma and baldness.
摘要:
Disclosed herein is a compound according to one of the formulas wherein R is (I) or (II). Additionally, pharmaceutically acceptable salt thereof, and methods of treating disease, medicaments, and compositions related thereto, are further elaborated herein.
摘要:
Disclosed herein are compounds having formula (I) wherein a dashed line represents the presence or absence of a bond; Y is an organic acid functional group, or an amide or ester thereof; or Y is hydroxymethyl or an ether thereof; or Y is a tetrazolyl functional group; A is -(CH 2 ) 6 -, cis -CH 2 CH=CH-(CH 2 ) 3 -, or -CH 2 C=C-(CH 2 ) 3 -, wherein 1 or 2 carbon atoms may be replaced by S or O; or A is -(CH 2 ) m -Ar-(CH 2 ) o - wherein Ar is interarylene or heterointerarylene, the sum of m and o is 1, 2, 3, or 4, and wherein 1 -CH 2 - may be replaced by S or O, and 1 -CH 2 -CH 2 - may be replaced by -CH=CH- or -C≡C-; U 1 and U 2 are independently selected from -H, =O, -OH, -F, -Cl, and -CN; and B is aryl or heteroaryl, for use as acular hypotensive agent.